Trading Signals: ADAP Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Fri. May. 28, 2021)(Adaptimmune Therapeutics plc)
| Market is closed on Thu. Dec. 3, 2020 | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 0% (three month average) | RSI | | Latest Price | $(0%) | Stocks Behave Similarly | Similar Stock List | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ADAP advance at 0% a week (0% probability) XLE(28%) XOP(28%) VIXM(27%) URA(24%) OIH(19%) | Factors Impacting ADAP price | ADAP will advance at least -0% in a week (0% probabilities). XLK(-25%) QQQ(-25%) TAN(-22%) VUG(-21%) IWF(-21%) | | | | | Relative Volatility | | | | Market Trend Strength | 0% (StdDev 0%) | Hourly BBV | -0.7 () | Intraday Trend | 0% | | | |
|
Adaptimmune Therapeutics Plc engages in the development of novel cancer immunotherapy products. Its specific peptide enhanced affinity receptor platform enables the engineering of T-cells to target and destroy cancer, including solid tumors. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom. |